WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010116090) THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/116090    International Application No.:    PCT/FR2010/050672
Publication Date: 14.10.2010 International Filing Date: 07.04.2010
Chapter 2 Demand Filed:    19.11.2010    
IPC:
A61K 31/517 (2006.01), A61P 9/00 (2006.01), A61K 9/00 (2006.01)
Applicants: SANOFI [FR/FR]; 174 avenue de France F-75013 Paris (FR) (For All Designated States Except US).
JANIAK, Philip [FR/FR]; (FR) (For US Only).
MARCINIAK, Gilbert [FR/FR]; (FR) (For US Only).
NAVE, Jean-François [FR/FR]; (FR) (For US Only).
VIVIANI, Fabrice [FR/FR]; (FR) (For US Only)
Inventors: JANIAK, Philip; (FR).
MARCINIAK, Gilbert; (FR).
NAVE, Jean-François; (FR).
VIVIANI, Fabrice; (FR)
Agent: VEINANTE, Aude; c/o sanofi-aventis Département Brevets 174 avenue de France F-75013 Paris (FR)
Priority Data:
0901755 09.04.2009 FR
Title (EN) THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES
(FR) APPLICATIONS THÉRAPEUTIQUES DANS LE DOMAINE CARDIOVASCULAIRE DE DÉRIVÉS DE QUINAZOLINEDIONE
Abstract: front page image
(EN)The subject of the present invention is the use of compounds of formula (I); in the base, hydrate or solvate form or in the form of their mixtures, as medicaments or for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease.
(FR)La présente invention a pour objet l'utilisation de composés de formule (I); à l'état de base, d'hydrate, de solvat, ou de leurs mélanges comme médicaments ou pour la préparation de médicaments destinés au traitement d'au moins une maladie cardiovasculaire et/ou à prévenir l'apparition d'au moins une maladie cardiovasculaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)